Stock Detail
SAVIENT PHARMACEUTICALS INC
Biotechnology
SVNT @ Yahoo Finance | SVNT Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $2.55 | $2.60 | $-0.01 | -0.39% | 0.00 | $2.56 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $2.52 | $2.50 | 861,123 | 181.17M | 1.7M | -2.52 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 2.65 | 2.60 | 2.55 | 2.50 | 2.45 |
Stock Profile
Savient Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products that target unmet medical needs. It sells and distributes a generic version of oxandrolone, which is used to promote weight gain following involuntary weight loss related to disease or medical condition. The company also sells and distributes the branded version of oxandrolone in the United States, under the name Oxandrin. Further, Savient Pharmaceuticals is developing Puricase, which is in Phase III clinical studies for the control of elevated levels of uric acid in the blood or hyperuricemia. It distributes its products to drug wholesaler customers in the United States. The company was founded in 1980 as Bio-Technology General Corp. and changed its name to Savient Pharmaceuticals, Inc. in 2003. Savient Pharmaceuticals is headquartered in East Brunswick, New Jersey.